Search
for
Sort by
Research 901–930 of 1000+
- Increased Insulin Sensitivity by Metformin Enhances Intense-Pulsed-Light-Assisted Hair Removal in Patients with Polycystic Ovary Syndrome
- Lack of association between clinical and biochemical hyperandrogenism in patients with polycystic ovary syndrome
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- New Criteria for the Clinical Diagnosis of Hyperandrogenism in Polycystic Ovarian Syndrome and the Risk of Overdiagnosis
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Exploring the therapeutic potential of metformin in polycystic ovary syndrome: focusing on hyperandrogenism in a sample of Iraqi women
- Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Generalised Glucocorticoid Resistance
- Hyperandrogenism in a Postmenopausal Woman Secondary to Testosterone Secreting Ovarian Stromal Tumor with Acoustic Schwannoma
- Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model
- Treatment of hyperandrogenism in women
- Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature
- Can serum vaspin levels predict clomiphene resistance in infertile women with PCOS?
- Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis Through a Mutated Glucocorticoid Receptor
- Prevalence of androgenic alopecia (AGA) in patients with polycystic ovarian syndrome (PCOS) and characterization of associated clinical and biochemical features
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Female Pattern Hair Loss